Hormonal & EndocrineFDA Approved / CompoundableA

Gonadorelin

GnRH / Factrel

Gonadorelin is the synthetic form of gonadotropin-releasing hormone (GnRH), a 10-amino acid hypothalamic peptide. FDA-approved for diagnosing hypogonadotropic hypogonadism and evaluating pituitary-gonadal function. Widely used in men on testosterone replacement therapy (TRT) to maintain testicular size, fertility, and endogenous testosterone production by preventing HPG axis suppression. Available through compounding pharmacies.

Observational report only — live community data. Not medical advice. Does not recommend doses, protocols, or treatments.
Studies cited
4
Research grade
A
Experience
99

Overall check-ins

Activity
74

Trackers & reports

Overview

About Gonadorelin

Gonadorelin is the synthetic form of gonadotropin-releasing hormone (GnRH), a 10-amino acid hypothalamic peptide. FDA-approved for diagnosing hypogonadotropic hypogonadism and evaluating pituitary-gonadal function. Widely used in men on testosterone replacement therapy (TRT) to maintain testicular size, fertility, and endogenous testosterone production by preventing HPG axis suppression. Available through compounding pharmacies.

Category
Hormonal & Endocrine
Regulatory status
FDA Approved / Compoundable
Also known as
GnRH / Factrel
Self-reports
25

Community

What 25 users report

25 community reports

Overall experience

From check-in ratings — separate from side effects logged below. Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.

Favorable 97% · Mixed 3% · Unfavorable overall 0%

Most reported benefits

Benefits users selected when logging a favorable or mixed check-in.

Libido
181

Most logged side effects

Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.

Nausea
2
Injection site irritation
2
Headache
1

Self-reported dose per injection

Median bucket: 100–200 mcg · Most common: 100–200 mcg

Reports span 50–400 mcg

50–100
59
100–200
62
200–400
60

Anonymized self-reports from PeptIQ users — not prescribing guidance. Buckets group similar logged amounts; open-ended top buckets mean “at least” that dose.

How repeat users are trending

Among repeat reporters, 87% said they felt similar to their last entry, 13% more positive, and 0% more negative.

Overall, repeat reporters leaned more positive than their previous entry.

Median gap between entries: 235 days · Based on 23 repeat reporters

Research

Cited research (3)

PubMed

Gonadotropin-releasing hormone agonists and antagonists in assisted reproduction

Al-Inany et al., 2016

Source
Wiki study page →

PubMed

Microglia Rank signaling regulates GnRH neuronal function and the hypothalamic-pituitary-gonadal axis

Collado-Sole et al., 2026

Source
Wiki study page →

Tools

Explore more

Help

Frequently asked

What do PeptIQ users report about Gonadorelin?

This page summarizes 25 anonymized self-reports from PeptIQ users who track Gonadorelin, including commonly reported effects and co-tracked peptides. These are observational patterns, not clinical outcomes.

How do side effects relate to overall experience for Gonadorelin?

PeptIQ separates overall check-in ratings (favorable, mixed, or unfavorable) from logged side effects like nausea or fatigue. Users often report benefits and side effects in the same check-in — a high experience score does not mean zero side effects were noted.

What research is cited for Gonadorelin?

3 sources are linked on this page, including PubMed articles, clinical trial registries, and FDA labels where applicable. Citations describe published research — not recommendations.

Is Gonadorelin safe to use?

This wiki does not assess safety or recommend use. Gonadorelin is listed as FDA Approved / Compoundable. Consult a licensed clinician for personal medical decisions.

What are the purported benefits and uses of Gonadorelin?

This wiki summarizes observational community reports and linked citations for Gonadorelin. It does not assert therapeutic benefits. See the cited research list on this page and the educational profile for Gonadorelin for study-level context — not medical advice.

What is the legal status of Gonadorelin?

Gonadorelin is listed in PeptIQ as FDA Approved / Compoundable. Regulatory status varies by jurisdiction and can change. This wiki does not provide legal advice; check current FDA and local rules and talk with a licensed clinician or counsel for personal decisions.

What are the known or theoretical side effects and risks of Gonadorelin?

Safety data quality for Gonadorelin varies widely by compound and study design. PeptIQ does not establish a risk profile here. Review primary literature, product labeling where applicable, and clinician guidance. Community self-reports are not a substitute for clinical evidence.

What is the current state of research on Gonadorelin?

This page links 3 indexed sources for Gonadorelin. Evidence maturity differs by application — some peptides have large human programs, others are mostly preclinical. Treat citation counts as literature volume, not proof of efficacy.